Versant Capital Management, Inc Altimmune, Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 230 shares of ALT stock, worth $832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
230
Previous 1,193
80.72%
Holding current value
$832
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALT
# of Institutions
204Shares Held
39.2MCall Options Held
2.02MPut Options Held
1.69M-
Black Rock Inc. New York, NY5.32MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$18.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$12.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$9.96 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$7 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $177M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...